Short answer
Revvity (RVTY) filed an 8-K current report with the SEC on May 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events). Filing contains only the signature page for REVVITY’s May 5, 2026 report.
Revvity 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Filing contains only the signature page for REVVITY’s May 5, 2026 report
- No earnings figures, reporting-period results, or operating metrics included in the provided text
Item 8.01 · Other Events
- Probable sale of China Immunodiagnostics assets for up to $200 million, subject to adjustments and closing conditions
- Management expects transaction closing in 2027, creating timing uncertainty for proceeds and portfolio impact
- Exhibit 99.2 provides unaudited pro forma financial statements reflecting the anticipated divestiture
- Transaction remains forward-looking and could change or fail due to execution and other risk factors
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Revvity 8-K filings
Get the next RVTY 8-K as it lands
Follow RVTY for push alerts, or ask the research agent what this filing means.